OTC Markets in India 2008-09


Published on

Published in: Travel, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

OTC Markets in India 2008-09

  1. 1. OTC Market in India
  2. 2. <ul><ul><li>Population - 1.1 Billion </li></ul></ul><ul><ul><li>GDP - 1,170,968 million USD </li></ul></ul><ul><ul><li>GDP growth rate - 9% </li></ul></ul><ul><ul><li>Gross national income per capita </li></ul></ul><ul><li>(PPP international $): 2,460 </li></ul><ul><ul><li>Total expenditure on health per capita </li></ul></ul><ul><li>(Intl $, 2006): 109 </li></ul><ul><ul><li>Total expenditure on health as % of GDP </li></ul></ul><ul><li>(2006): 4.9 </li></ul><ul><li>Source: World Health Statistics 2008 </li></ul>
  3. 3. <ul><ul><li>700 million people have no access to specialist care </li></ul></ul><ul><ul><li>80% of specialists live in urban areas </li></ul></ul>
  4. 4. <ul><ul><li>Currently the Indian OTC market (i.e. advertised non-prescription medicines) is estimated to represent approximately USD 1,793 million </li></ul></ul><ul><ul><li>OTC sales account for about 18% of total pharmaceutical sales </li></ul></ul>
  5. 6. Private health expenditure as percentage of GDP
  6. 7. Doctor patient ratio in India is 1:1700
  7. 9. 30% of Beds for >70% of population
  8. 10. Most money spent on Vaccination and primary prevention.
  9. 11. <ul><li>Growth rate </li></ul><ul><ul><li>Rural 12.75% </li></ul></ul><ul><ul><li>Urban 15.15% </li></ul></ul>
  10. 13. Indian behavior in illness .
  11. 14. Datamonitor Points of sale.
  12. 15. Datamonitor
  13. 16. “ Maximum number of OTC drugs sold by qualified chemists and pharmacists are from branded companies like Pfizer Inc., share of which is estimated at about 8%, followed by Sanofi-Aventis 7% and Johnson & Johnson 5.5%..” -Assocham study, 2008. The Associated Chambers of Commerce and Industry of India (ASSOCHAM)
  14. 17. <ul><ul><li>Currently, aches/pains, cough, colds, hyperacidity, minor topical infections and indigestion are major OTC categories. </li></ul></ul><ul><ul><li>Emerging categories include cuts, wounds and burns, muscle pains and sprains, diarrhea and constipation. </li></ul></ul>
  15. 18. <ul><ul><li>'Prescription drugs' fall under two schedules of the Drug Rules, 1945 – </li></ul></ul><ul><li>Schedule H and Schedule X . </li></ul><ul><ul><li>No separate list of OTC drugs </li></ul></ul><ul><ul><li>What is not prohibited is permitted. Thus, all the drugs which are not specified in the list of 'prescription drugs' must be considered as non-prescription drugs (or the OTC drugs). </li></ul></ul>
  16. 19. <ul><ul><li>The Drug & Magic Remedies (Objectionable Advertisement) Act mentions a list of ailments for which no advertising is permitted. </li></ul></ul><ul><ul><li>The DCGI’s office in collaboration with the Organisation of Pharmaceutical Producers of India (OPPI) -has released a Voluntary Code on OTC Advertising which is being followed by all OPPI member companies. </li></ul></ul><ul><ul><li>There is also an OPPI Code of Pharmaceutical Marketing Practices , January 2007, based on the IFPMA code. </li></ul></ul>http://www.indiaoppi.com/OPPI%20Code%20of%20Marketing%202007.pdf
  17. 20. • digestives • antacids • antiflatulents • cold rubs and analgesic balms/creams • vitamins/tonics/health supplements (especially herbals) • medicated skin treatment • analgesic /cold tablets • antiseptic creams/liquids • glucose powders • cough liquids • throat lozenges • medicated dressings (band-aids) • baby gripe water.
  18. 21. <ul><ul><li>OTC Drug Marketing – Global Trends and Indian Experiences Ajith Paninchukunnath* </li></ul></ul><ul><ul><li>The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market-William Greene, U.S. International Trade Commission, May 2007 </li></ul></ul><ul><ul><li>India’s Rising Growth Potential- GS GLOBAL ECONOMIC WEBSITE Economic Research from the GS Institutional Portal at https://portal.gs.com </li></ul></ul>
  19. 22. <ul><ul><li>Central Drugs Standard Control Organization </li></ul></ul><ul><li>Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India </li></ul><ul><ul><li>India OTC Profile 2008 </li></ul></ul>http://www.indiaoppi.com/India%20OTC%20Profile%202008.pdf <ul><ul><li>Census, Government of India </li></ul></ul><ul><li>Economic survey-2008 </li></ul>
  20. 23. <ul><ul><li>Healthcare in India </li></ul></ul><ul><li>-Emerging market report 2007 </li></ul><ul><ul><li>OTC Marketing of Drugs </li></ul></ul><ul><li>Vijay Bhangale*- International Marketing Conference on </li></ul><ul><li>Marketing & Society, April, 2007, IIMK </li></ul>Dr.Neelesh Bhandari M.B.B.S (AFMC),M.D (Path) P.G.P in Human Rights Advisor ( Medical Communications) Mark IV Animation Studios Pvt. Ltd .